ORE-1001
- Generic Name
- ORE-1001
- Drug Type
- Small Molecule
- Chemical Formula
- C19H23Cl2N3O4
- CAS Number
- 305335-31-3
- Unique Ingredient Identifier
- 4LD0ZHV25K
- Background
ORE1001 has been used in trials studying the treatment of Mild to Moderate Ulcerative Colitis. It is an ACE2 inhibitor.
Safety and Activity of ORE1001 in Subjects With Ulcerative Colitis
- First Posted Date
- 2009-12-25
- Last Posted Date
- 2011-06-08
- Lead Sponsor
- Ore Pharmaceuticals, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT01039597
- Locations
- 🇮🇳
B.Y.L. Nair Hospital, Bombay, Maharashtra, India
🇮🇳St. John's Medical College Hospital, Bangalore, Karnatka, India
🇮🇳Gut-n-HEPA Care, Indore, Madhya Pradesh, India
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath